Biobank, personalised medicinePrecision therapeutics: optimising early d... Precision medicine tailors therapeutics to individual patients’ diseases, and is seen as the future of clinical practice. With significant time and financial investments being made in developing … more ➔
SpainSpain: An overview over a sector that has...After two years of unprecedented growth driven by the pandemic, investment attracted by Spanish biotech companies has stabilised, and they face significant challenges, positioning biotechnology as a … more ➔
Artificial intelligenceAI – tool or trouble? Depending on who you talk to, artificial intelligence (AI) is either a saviour or an enslaver. The concerns range from loss of jobs through to robots running society. However, in the life sciences, … more ➔
Novel FoodTasteful plant proteinConventional meat production contributes to 15% of the global greenhouse gas emissions, high energy consumption and land use change. Belgian Paleo NV produces alternative protein from myoglobins of different … more ➔
Sandoz, BiosimilarsBiosimilars climb the alpsGeneric and biosimilar manufacturer Sandoz is expanding with a new biologics production facility in Lendava, Slovenia to prepare for more demand in Europe for biosimilar products. more ➔
BiobankSweden: Biobank lawThe Sweden Biobank Act governs the collection, storage, and usage of identifiable human material samples for specific purposes. more ➔
SwissMega Series C in SwitzerlandAlentis is the only company developing potential treatments for solid cancers and fibrosis targeting Claudin-1 (CLDN1). The molecule is significantly involved in the tight junction between cells. Now … more ➔
GreeceHow to clean with bacteriaFrom bacteria to cellulose fibers and lab grown paper. A greek project paves the way to save trees. more ➔
GreeceFirst island with zero wasteTilos marks the first island to achieve 100% diversion from landfill with an 87% recycling rate. more ➔
CRONew headquarter in KrakowThe new Krakow headquarters of preclinical CRO Selvita have opened. more ➔
